Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0012505 | endomembrane system | 2 | 2 |
GO:0016020 | membrane | 2 | 14 |
GO:0031201 | SNARE complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0098796 | membrane protein complex | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 14 |
Related structures:
AlphaFold database: Q4QDM0
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 2 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006906 | vesicle fusion | 6 | 2 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0008104 | protein localization | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0016050 | vesicle organization | 5 | 2 |
GO:0022406 | membrane docking | 2 | 2 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0048278 | vesicle docking | 4 | 2 |
GO:0048284 | organelle fusion | 5 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051640 | organelle localization | 2 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0061024 | membrane organization | 4 | 2 |
GO:0061025 | membrane fusion | 5 | 2 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0090174 | organelle membrane fusion | 6 | 2 |
GO:0140056 | organelle localization by membrane tethering | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000149 | SNARE binding | 3 | 2 |
GO:0005484 | SNAP receptor activity | 3 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0005515 | protein binding | 2 | 2 |
GO:0030674 | protein-macromolecule adaptor activity | 2 | 2 |
GO:0060090 | molecular adaptor activity | 1 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 175 | 179 | PF00656 | 0.593 |
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.389 |
CLV_NRD_NRD_1 | 159 | 161 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 257 | 259 | PF00675 | 0.317 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.284 |
CLV_NRD_NRD_1 | 82 | 84 | PF00675 | 0.344 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.353 |
CLV_PCSK_KEX2_1 | 147 | 149 | PF00082 | 0.384 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.367 |
CLV_PCSK_KEX2_1 | 257 | 259 | PF00082 | 0.314 |
CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.411 |
CLV_PCSK_PC1ET2_1 | 147 | 149 | PF00082 | 0.505 |
CLV_PCSK_PC7_1 | 253 | 259 | PF00082 | 0.351 |
CLV_PCSK_SKI1_1 | 257 | 261 | PF00082 | 0.329 |
CLV_PCSK_SKI1_1 | 27 | 31 | PF00082 | 0.353 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.345 |
DEG_APCC_DBOX_1 | 151 | 159 | PF00400 | 0.579 |
DEG_APCC_DBOX_1 | 59 | 67 | PF00400 | 0.587 |
DEG_APCC_KENBOX_2 | 85 | 89 | PF00400 | 0.528 |
DOC_MAPK_gen_1 | 89 | 100 | PF00069 | 0.529 |
DOC_MAPK_MEF2A_6 | 219 | 227 | PF00069 | 0.484 |
DOC_USP7_MATH_1 | 93 | 97 | PF00917 | 0.577 |
DOC_USP7_UBL2_3 | 193 | 197 | PF12436 | 0.552 |
DOC_USP7_UBL2_3 | 260 | 264 | PF12436 | 0.627 |
DOC_USP7_UBL2_3 | 86 | 90 | PF12436 | 0.531 |
LIG_14-3-3_CanoR_1 | 108 | 116 | PF00244 | 0.629 |
LIG_14-3-3_CanoR_1 | 257 | 263 | PF00244 | 0.472 |
LIG_Actin_WH2_2 | 248 | 266 | PF00022 | 0.499 |
LIG_AP2alpha_2 | 16 | 18 | PF02296 | 0.523 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.632 |
LIG_BIR_III_3 | 1 | 5 | PF00653 | 0.590 |
LIG_CaM_IQ_9 | 140 | 156 | PF13499 | 0.622 |
LIG_FHA_1 | 239 | 245 | PF00498 | 0.654 |
LIG_FHA_1 | 247 | 253 | PF00498 | 0.616 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.642 |
LIG_FHA_2 | 183 | 189 | PF00498 | 0.561 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.488 |
LIG_LIR_Gen_1 | 15 | 26 | PF02991 | 0.602 |
LIG_LIR_Nem_3 | 15 | 21 | PF02991 | 0.634 |
LIG_LIR_Nem_3 | 285 | 290 | PF02991 | 0.257 |
LIG_LRP6_Inhibitor_1 | 54 | 60 | PF00058 | 0.281 |
LIG_PCNA_yPIPBox_3 | 253 | 263 | PF02747 | 0.508 |
LIG_Pex14_2 | 288 | 292 | PF04695 | 0.381 |
LIG_SH2_GRB2like | 112 | 115 | PF00017 | 0.480 |
LIG_SH2_STAP1 | 112 | 116 | PF00017 | 0.481 |
LIG_SH2_STAT5 | 274 | 277 | PF00017 | 0.279 |
LIG_SUMO_SIM_anti_2 | 173 | 180 | PF11976 | 0.594 |
LIG_SUMO_SIM_par_1 | 280 | 285 | PF11976 | 0.202 |
LIG_TRAF2_1 | 139 | 142 | PF00917 | 0.667 |
LIG_TRAF2_1 | 185 | 188 | PF00917 | 0.553 |
LIG_TRAF2_1 | 69 | 72 | PF00917 | 0.624 |
LIG_UBA3_1 | 155 | 161 | PF00899 | 0.647 |
LIG_WRC_WIRS_1 | 259 | 264 | PF05994 | 0.510 |
MOD_CK1_1 | 165 | 171 | PF00069 | 0.562 |
MOD_CK2_1 | 136 | 142 | PF00069 | 0.625 |
MOD_CK2_1 | 182 | 188 | PF00069 | 0.723 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.488 |
MOD_Cter_Amidation | 106 | 109 | PF01082 | 0.382 |
MOD_Cter_Amidation | 145 | 148 | PF01082 | 0.353 |
MOD_GlcNHglycan | 116 | 119 | PF01048 | 0.383 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.511 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.518 |
MOD_N-GLC_1 | 162 | 167 | PF02516 | 0.446 |
MOD_N-GLC_2 | 41 | 43 | PF02516 | 0.293 |
MOD_NEK2_1 | 176 | 181 | PF00069 | 0.601 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.578 |
MOD_PIKK_1 | 107 | 113 | PF00454 | 0.518 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.543 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.592 |
MOD_Plk_1 | 66 | 72 | PF00069 | 0.520 |
MOD_Plk_2-3 | 136 | 142 | PF00069 | 0.650 |
MOD_Plk_4 | 258 | 264 | PF00069 | 0.494 |
MOD_SUMO_for_1 | 4 | 7 | PF00179 | 0.702 |
TRG_DiLeu_BaEn_1 | 72 | 77 | PF01217 | 0.589 |
TRG_ER_diArg_1 | 158 | 160 | PF00400 | 0.596 |
TRG_ER_diArg_1 | 257 | 259 | PF00400 | 0.515 |
TRG_ER_diArg_1 | 82 | 84 | PF00400 | 0.689 |
TRG_NES_CRM1_1 | 68 | 81 | PF08389 | 0.467 |
TRG_NLS_MonoCore_2 | 88 | 93 | PF00514 | 0.572 |
TRG_NLS_MonoExtC_3 | 88 | 93 | PF00514 | 0.544 |
TRG_NLS_MonoExtN_4 | 86 | 93 | PF00514 | 0.614 |
TRG_Pf-PMV_PEXEL_1 | 82 | 87 | PF00026 | 0.406 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1P9J7 | Leptomonas seymouri | 70% | 92% |
A0A0S4IV64 | Bodo saltans | 43% | 86% |
A0A0S4IVZ4 | Bodo saltans | 36% | 89% |
A0A0S4IZ68 | Bodo saltans | 42% | 89% |
A0A1X0P6H2 | Trypanosomatidae | 55% | 91% |
A0A3R7LL06 | Trypanosoma rangeli | 50% | 91% |
A0A3S7WV65 | Leishmania donovani | 92% | 100% |
A4H9V8 | Leishmania braziliensis | 76% | 92% |
A4HY40 | Leishmania infantum | 92% | 100% |
D0A0C4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 91% |
E9ARV3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 92% |
V5BS89 | Trypanosoma cruzi | 52% | 91% |